viewEmpower Clinics Inc.

Empower Clinics inks strategic tie-up with Endocanna Health to sell endocannabinoid DNA test kits

The EndoDNA test kits available in the US allow patients to take control of their health by utilizing cannabis products specifically suited to them

Heritage Cannabis - Empower Clinics Inc in strategic tie-up with Endocanna Health Inc to sell endocannabinoid DNA test kits
Empower will make the Endocanna kits available to its medical clinics in Oregon, Arizona, Washington State and Nevada

Empower Clinics Inc (CSE:CBDT) (OTCMKTS:EPWCF) said Wednesday that it has formed a strategic partnership with biotechnology company Endocanna Health Inc to sell its endocannabinioid DNA test kits through its cannabis healthcare clinics.

In a statement, the company said Los Angeles-based Endocanna Health , a partly-owned subsidiary of Heritage Cannabis (CSE:CANN), will make its patent-pending endocannabinoid DNA test kits for Empower.

It will also license its proprietary DNA technology to Seattle-based Empower Clinics which operates a network of medical cannabis healthcare clinics in Washington State, Oregon, Arizona, Illinois and Nevada. The physician-staffed clinics focus on helping nearly 165,000 patients through the use of medical cannabis.

Empower said it plans to include the EndoDNA test kits as a “standard offering” through its Sun Valley Health franchise program and has immediately started the roll-out in the United States.

"The Endocanna DNA test kit can give our physicians the potential to have even greater insight into each individual patient's propensity for success, on how CBD based therapies may interact with their individual regulatory system," said Empower Clinics CEO Steven McAuley in a statement.

Personalized healthcare

McAuley said the strategic tie-up is geared towards getting patients the best care and advice using the “most advanced technology” available.

The kits are designed to provide consumers with personalized data on how CBD and other cannabinoids may interact with their body. The technology allows the company to provide patients with science-backed cannabis product suggestions based on their specific DNA.

For most of history, the effects of cannabis on the human body were little understood. Then, in the 1990s, scientists discovered endocannabinoids, the natural cannabis-like molecules produced by the human body. It appears the main function of the endocannabinoid system is to regulate a variety of physiological and cognitive processes including appetite, pain-sensation, mood, and memory.

Endocanna Health co-founder and CEO Len May said that by using the DNA report, Empower can provide a “cannabinoid wellness protocol” tailored to each patient's individual needs.

“Empower and their Sun Valley Health clinic network, provides an immediate opportunity for us to work with physicians and patients to develop advanced science surrounding the endocannabinioid system and CBD based therapies," May added.

Contact Uttara Choudhury at uttara@proactiveinvestors.com

Follow her on Twitter: @UttaraProactive 

Quick facts: Empower Clinics Inc.


Price: 0.47 CAD

Market Cap: $156.7 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...


Empower Clinic’s Medi-Collective expands future locations to 33 covering BC,...

Empower Clinics CEO Steven McAuley joined Steve Darling from Proactive to shares news the company is expanding their national clinic rollout strategy and are preparing to open their next Medi-Collective" clinic in Etobicoke, Ontario on October 18th. McAuley also shared with Proactive the...

2 hours, 12 minutes ago

2 min read